ATE343578T1 - Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten - Google Patents

Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten

Info

Publication number
ATE343578T1
ATE343578T1 AT02727742T AT02727742T ATE343578T1 AT E343578 T1 ATE343578 T1 AT E343578T1 AT 02727742 T AT02727742 T AT 02727742T AT 02727742 T AT02727742 T AT 02727742T AT E343578 T1 ATE343578 T1 AT E343578T1
Authority
AT
Austria
Prior art keywords
sub
crf receptor
receptor antagonists
tetraaza
tri
Prior art date
Application number
AT02727742T
Other languages
English (en)
Inventor
Fabio Romano Di
Gabriella Gentile
Mustapha Haddach
Yves St-Denis
John Patrick Williams
Original Assignee
Neurocrine Biosciences Inc
Sb Pharmco Puerto Rico Inc Csc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc, Sb Pharmco Puerto Rico Inc Csc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of ATE343578T1 publication Critical patent/ATE343578T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT02727742T 2001-05-21 2002-05-21 Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten ATE343578T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29266001P 2001-05-21 2001-05-21

Publications (1)

Publication Number Publication Date
ATE343578T1 true ATE343578T1 (de) 2006-11-15

Family

ID=23125629

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727742T ATE343578T1 (de) 2001-05-21 2002-05-21 Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten

Country Status (21)

Country Link
US (1) US7446108B2 (de)
EP (1) EP1392689B1 (de)
JP (1) JP2004530702A (de)
KR (1) KR20040018260A (de)
CN (1) CN1529705A (de)
AT (1) ATE343578T1 (de)
AU (1) AU2002257939B2 (de)
BR (1) BR0209947A (de)
CA (1) CA2450535A1 (de)
CO (1) CO5540310A2 (de)
CZ (1) CZ20033165A3 (de)
DE (1) DE60215637T2 (de)
ES (1) ES2274972T3 (de)
HU (1) HUP0400854A2 (de)
IL (1) IL158806A0 (de)
MX (1) MXPA03010635A (de)
NO (1) NO20035148D0 (de)
NZ (1) NZ529471A (de)
PL (1) PL367771A1 (de)
WO (1) WO2002094826A1 (de)
ZA (1) ZA200308810B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
DE602005000676T2 (de) 2004-01-06 2007-11-22 Taisho Pharmaceutical Co., Ltd. Triazacyclopenta[cd]indenderivate
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2414359A1 (de) 2009-03-31 2012-02-08 ArQule, Inc. Perikondensierte pyrazolopyrimidinverbindungen
ES2540964T3 (es) * 2009-06-08 2015-07-15 Takeda Pharmaceutical Company Limited Compuestos de dihidropirrolonaftiridinona como inhibidores de JAK
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04211063A (ja) * 1990-03-05 1992-08-03 Takeda Chem Ind Ltd 縮合三環性複素環化合物、その製造法、用途及び中間体
ZA973884B (en) 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
JP3621706B2 (ja) * 1996-08-28 2005-02-16 ファイザー・インク 置換された６，５―ヘテロ―二環式誘導体
ES2180338T3 (es) * 1998-11-12 2003-02-01 Neurocrine Biosciences Inc Antagonistas del receptor de crf y metodos relacionados.
GB0117395D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1529705A (zh) 2004-09-15
JP2004530702A (ja) 2004-10-07
CA2450535A1 (en) 2002-11-28
IL158806A0 (en) 2004-05-12
CO5540310A2 (es) 2005-07-29
KR20040018260A (ko) 2004-03-02
AU2002257939B2 (en) 2006-08-24
WO2002094826A1 (en) 2002-11-28
ES2274972T3 (es) 2007-06-01
PL367771A1 (en) 2005-03-07
BR0209947A (pt) 2004-04-27
US7446108B2 (en) 2008-11-04
NZ529471A (en) 2005-12-23
US20040198726A1 (en) 2004-10-07
EP1392689A1 (de) 2004-03-03
DE60215637D1 (de) 2006-12-07
HUP0400854A2 (hu) 2004-08-30
MXPA03010635A (es) 2004-12-06
ZA200308810B (en) 2004-11-30
NO20035148D0 (no) 2003-11-19
EP1392689B1 (de) 2006-10-25
CZ20033165A3 (cs) 2004-10-13
DE60215637T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
NO20012194D0 (no) CRF-reseptorantagonister og tilhörende fremgangsmåter
DK1646389T3 (da) Pyrimidin-2,4-dionderivater som gonadotropinfrigörende hormonreceptorantagonister
IL155702A0 (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor
TR200102178T2 (tr) CRF reseptör antagonistleri ve bunlarla ilgili yöntemler.
DE602004017196D1 (de) Kondensierte azabicyclische verbindungen, die den vanilloidrezeptorsubtyp 1 (vr1)- rezeptor inhibieren
DE602004020638D1 (de) Pyrimidin-2,4-dion-derivate als gonadotropin freisetzende hormon-rezeptor-antagonisten
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
ATE343578T1 (de) Tri- und tetraaza-acenaphthylen-derivate als crf- rezeptor-antagonisten
NO20063230L (no) CRF receptorantagonister og fremgangsmater for fremstilling derav
AU2001261850A1 (en) Crf receptor antagonists and methods relating thereto
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
AU2001263329A1 (en) Crf receptor antagonists and methods relating thereto
DE602004012318D1 (de) Crf-rezeptorantagonisten und diese betreffende verfahren
DE60227113D1 (de) Kondensierte camptothecine als antitumormittel
GB0311349D0 (en) Therapeutic agents, compositions, preparations and uses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties